Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women

Females are disproportionately affected by constipation, which is often aggravated during pregnancy. Bowel function also changes during the luteal phase of the menstrual cycle. The aim was to compare the effects of acute administration of female sex steroids on gastric emptying, small bowel transit and colonic transit in healthy postmenopausal subjects. A second aim was to determine whether withdrawal of the hormones was associated with a change in transit. Forty-nine postmenopausal females were randomized to receive for 7 days 400 mg day(-1) micronized progesterone, 0.2 mg day(-1) oestradiol, combination of the two, or placebo. Treatment groups were balanced on age. Participants underwent whole gut transit measurement by scintigraphy using a 99m-labeled technetium-egg meal and 111-labeled indium-charcoal via a delayed-release capsule. Transit measurement was repeated after withdrawal of the study medications. The primary endpoints were ascending colon (AC) emptying half-life time (t1/2) and colonic geometric centre (GC) at 24 h. Secondary analysis variables were GC at 4 and 48 h, gastric emptying t1/2 and colonic filling at 6 h. There was a significant overall effect of progesterone on colonic transit with shorter AC emptying t1/2 and significantly greater colonic GC at 48 h. No transit endpoints were altered by oestradiol or combined hormonal treatment relative to placebo. Oestradiol and progesterone resulted in looser stool consistency. Withdrawal of the hormone supplement was not associated with significant alteration in transit. Micronized progesterone does not retard colonic transit in postmenopausal females.     

The Relationship Between Daily Life Stress and Gastrointestinal Symptoms in Women with Irritable Bowel Syndrome

Research on irritable bowel syndrome (IBS), a functional disorder of the gastrointestinal (GI) system, has linked GI symptoms to stress. This study examined the relationship between daily stress and GI symptoms across women and within woman in IBS patients (n = 26), IBS nonpatients (IBS-NP; n = 23), and controls (n = 26), controlling for menstrual cycle phase. Women (ages 20–45) completed daily health diaries for two cycles in which they monitored daily GI symptoms and stress levels. The Life Event Survey (LES) was used as a retrospective measure of self-reported stress. The across-women analyses showed higher mean GI symptoms and stress in the IBS and IBS-NP groups relative to controls but no group differences in LES scores. The within-woman analyses found a significant and positive relationship between daily stress and daily symptoms in both the IBS-NP and the IBS groups. Controlling for menstrual cycle had no substantial impact on the results.     

孕期心理干预对产后情绪的影响

目的探讨孕期对孕妇及家属给予心理干预对产后抑郁、焦虑情绪的影响。方法对270名孕妇和268名孕妇家属分别进行心理干预,对照组269名孕妇接受一般教育,干预组及对照组在孕期填写一般情况调查表及SDS、SAS量表,产后1周、1个月、6个月填写SDS、SAS量表。结果干预组产后抑郁焦虑发生率较对照组明显降低(P<0.05)。结论孕期加强对孕妇及家属的心理教育有利于稳定情绪,降低产后抑郁、焦虑的发生。     

产后出血的预防和护理（附117例分析）

目的探讨产后出血的原因与护理、预防的方法，确保产妇安全。方法回顾性分析本组产妇分娩后大出血的病情观察、护理、治疗和预防的方法。结果经过精心护理和积极治疗，及时止血，解除了病人的紧张情绪，117例病人平均住院8d，均痊愈出院。结论加强对产妇，特别是产后出血病人的护理，对预防和及时控制出血，加快病人康复有重要意义。     

Breast Volume Measurement in Young Chinese Women and Clinical Applications

The authors carried out research on breast volume and body surface anatomy of 125 women. As a result, an average breast volume for Chinese women was obtained (325.36 ± 12.66 ml), and a table with several linear equations for calculating breast volume was derived. The authors applied these results to their clinical work and succeeded in making mammaplasty more precise in 178 patients.     

育龄妇女、孕妇及乳母碘营养状况调查

目的 了解缺碘地区食用合格碘盐的育龄妇女和孕妇及乳母碘营养状况。方法 对病区育龄妇女和孕妇及乳母进行观察。采用酸消化砷铈接触法及全定量直接滴定法分别检测尿碘，乳碘和盐碘含量。结果 育龄妇女和孕妇及乳母尿碘含量分别为219.37μg/L，203.98μg/L，178.55μg/L，尿碘值小于100μg/L占24.14%，三组人群尿碘水平依次降低，但差异未显示统计学意义；乳碘值为122.72μg/L，小于100μg/L达33.93%，提示应关注特需人群的碘营养问题。结论 应开展对育龄妇女和孕妇及乳母的尿碘监测。以指导合理补碘，防止胎儿和婴幼儿碘营养不良的发生。     

山东省德州地区已婚育龄妇女弓形虫筛查状况分析

目的:了解已婚育龄妇女弓形虫感染情况以及探讨弓形虫的感染途径、感染与不良生育的关系。方法:于1998年12月～2000年12月采用ELISE方法对1042例育龄妇女进行了TOX-IgM的筛查及有关情况调查。结果:本市已婚育龄妇女TOX-IgM平均感染率为12.18％,正常妊娠组及不良生育组显著高于未孕组(P<0.05);郊区妇女高于市区妇女(P<0.05);有动物接触史及有生食习惯的妇女显著高于无接触史及生食习惯者(P<0.05)。结论:TOX感染是引起不良生育的重要原因之一。建议育龄妇女孕前孕期加强TOX筛查工作,以及早诊治;加强健康教育,改变不良生活习惯;加强水源、粪便等卫生管理。     

Cyclic hormonal replacement therapy after the menopause: Transdermal versus oral treatment

Summary In an open, randomized, comparative, between-patient trial, 45 postmenopausal women were treated for 4 months with cyclical transdermal oestradiol 0.05 mg per day or oral conjugated equine oestrogens 0.625 mg per day, in both cases, plus, medroxyprogesterone acetate 10 mg per day on the last 8 days of each cycle. Similar relief from postmenopausal symptoms was obtained with both treatments. Post-treatment histological evaluation of the endometrium did not reveal neoplastic or hyperplastic change in any patient.Early follicular-phase plasma oestradiol levels were observed only after transdermal oestradiol. There was a significant reduction in serum total cholesterol and LDL cholesterol in both treatment groups, with no difference between treatments, whereas serum triglyceride levels were decreased only by transdermal oestradiol. Plasma calcium and phosphorus fell significantly and serum intact parathyroid hormone rose significantly, with no difference between the therapies. No significant changes were observed in clotting factors.Transdermal oestradiol appears to be an effective and safe hormonal replacement therapy, and this route of administration may be responsible for the more useful action of the drug on serum lipids and plasma oestradiol levels.     

长沙地区孕妇CMV感染状况及其临床追踪观察

研究了７７例长沙地区孕、产妇的宫颈排毒（ＣＭＶ）情况及母、婴的免疫状态，并对宫颈排毒及ＣＭＶ一ＩｇＭ阳性的母亲所生小孩进行临床追踪。结果显示：孕妇宫颈排毒率为４．５％，抗ＣＭＶ－ＩｇＧ和抗ＣＭＶ－ＩｇＭ阳性率分别为７７％和１３％，５９例脐血ＣＭＶ－ＩｇＭ阴性。宫颈排毒的３例其抗体检测抗ＣＭＶ－ＩｇＧ均阳性，抗ＣＭＶ－ＩｇＭ仅一例阳性。作者认为，对妊娠期活动性ＣＭＶ感染的诊断，仅检测抗ＣＭＶ－ＩｇＧ和抗ＣＭＶ－ＩｇＭ抗体滴度仍不足，尚须结合病毒分离和其它检测手段。